Your account is not claimed yet. You can sign up with ORCID to claim your account.

Penelope J Duerksen-Hughes (Penelope Duerksen-Hughes)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Nutrients

Oxidative medicine and cellular longevity

Translational stroke research

Advances in pharmacological and pharmaceutical sciences

Loma Linda University

Emory University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Loma Linda University Sep 1o 2000

United States

Associate Dean :: Basic Science

Education History

Emory University Sep 1o 1982 - May 28o 1987

United States

PHD :: Biochemistry

Publications

Dani Ran Castillo, Won Jin Jeon, Daniel Park, Bryan Pham, Chieh Yang, Bowon Joung, Jin Hyun Moon, Jae Lee, Esther G Chong, Kiwon Park, Mark E Reeves, Penelope J Duerksen-Hughes, Hamid R Mirshahidi, Saied Mirshahidi
Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management. International journal of molecular sciences 24 (14) (2023)
Fayth L Miles, Michael J Orlich, Andrew Mashchak, Paulette D Chandler, Johanna W Lampe, Penelope J Duerksen-Hughes, Gary E Fraser
The Biology of Veganism: Plasma Metabolomics Analysis Reveals Distinct Profiles of Vegans and Non-Vegetarians in the Adventist Health Study-2 Cohort. Nutrients 14 (3) (2022)
Sonia N Whang, Vivek D Shah, Lu Pu, Parthiv Sheth, Gina N Lucas, Joanne Lee, Michael Lee, Curtis Lacy, Penelope J Duerksen-Hughes, Valeri Filippov, David J H Lee, Jennifer Veltman, Kanwaljeet Maken, Mark E Reeves, Wesley Tait Stevens, Paul Herrmann, Huynh Cao, Eric Lau
Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature. Pathogens (Basel, Switzerland) 11 (9) (2022)
Lennox Chitsike, Penelope J Duerksen-Hughes
PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6. Molecules (Basel, Switzerland) 26 (10) (2021)
Lennox Chitsike, Penelope J Duerksen-Hughes
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics. Virology journal 18 (1) (2021)
Lennox Chitsike, John Krstenansky, Penelope J Duerksen-Hughes
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics. Advances in pharmacological and pharmaceutical sciences 2021 (2021)
Valery Filippov, Karen Jaceldo-Siegl, Alexey Eroshkin, Vasiliy Loskutov, Xin Chen, Charles Wang, Penelope J Duerksen-Hughes
Methylomes in Vegans versus Pescatarians and Nonvegetarians. Epigenomes 4 (4) (2020)
Lennox Chitsike, Penelope J Duerksen-Hughes
The Potential of Immune Checkpoint Blockade in Cervical Cancer: Can Combinatorial Regimens Maximize Response? A Review of the Literature. Current treatment options in oncology 21 (12) (2020)
Prativa Sherchan, Fayth Miles, Michael Orlich, Gary Fraser, John H Zhang, Konrad Talbot, Penelope J Duerksen-Hughes
Effects of Lifestyle Factors on Cognitive Resilience: Commentary on "What This Sunny, Religious Town in California Teaches Us About Living Longer". Translational stroke research 11 (2) (2020)
Meghri Katerji, Maria Filippova, Penelope J Duerksen-Hughes
Approaches and Methods to Measure Oxidative Stress in Clinical Samples: Research Applications in the Cancer Field. Oxidative medicine and cellular longevity 2019 (2019)

Penelope J Duerksen-Hughes.css-eqlu8i{font-size:small;padding-left:4px;} (Penelope Duerksen-Hughes)

Publication Activity (10 Years)

Top Topics

Top Venues

Penelope J Duerksen-Hughes (Penelope Duerksen-Hughes)